SCHEMBL7036555

SCHEMBL7036555

CCCCCN[C@@]1(n2ccc(N)nc2=O)O[C@H](CO)[C@@H](O)[C@H]1O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.43
THRB P10828 1/20 0.43
MTOR P42345 1/20 0.43
MDM2 Q00987 1/20 0.43
NCOA1 Q15788 1/20 0.43
NCOA3 Q9Y6Q9 1/20 0.43
PDE3A Q14432 3/20 0.41
PDE4D Q08499 1/20 0.41
SLC29A1 Q99808 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.39
POLB P06746 1/20 0.39
ALDH1A1 P00352 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
FGFR1 P11362 4/20 0.35
CACNA1F O60840 2/20 0.33
ALB P02768 2/20 0.33
MAPT P10636 2/20 0.33
CACNA1D Q01668 2/20 0.33
CACNA1S Q13698 2/20 0.33
CACNA1C Q13936 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6060585 0.81 LMNA (0.45) LMNATHRBMTORMDM2NCOA1
SCHEMBL25407209 0.80 LMNA (0.44) LMNATHRBMTORMDM2NCOA1
SCHEMBL28645147 0.80 LMNA (0.46) LMNATHRBMTORMDM2NCOA1
SCHEMBL28643489 0.79 LMNA (0.46) LMNATHRBMTORMDM2NCOA1
SCHEMBL15561361 0.78 LMNA (0.44) LMNATHRBMTORMDM2NCOA1
SCHEMBL9047407 0.78 PDE3A (0.42) LMNATHRBMTORMDM2NCOA1
SCHEMBL31305353 0.78 PDE3A (0.42) LMNATHRBMTORMDM2NCOA1
SCHEMBL1403455 0.78 PDE3A (0.42) LMNATHRBMTORMDM2NCOA1
SCHEMBL15239320 0.78 LMNA (0.47) LMNATHRBMTORMDM2NCOA1
SCHEMBL1896532 0.77 LMNA (0.49) LMNATHRBMTORMDM2NCOA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1487855-A2 METHOD OF USING MODIFIED OLIGONUCLEOTIDES FOR HEPATIC DELIVERY ISIS Pharmaceuticals, Inc. (US) 2004-12-22 EP disclosed
WO-2003072711-A2 METHOD OF USING MODIFIED OLIGONUCLEOTIDES FOR HEPATIC DELIVERY ISIS PHARMACEUTICALS, INC. (US) 2003-09-04 WO disclosed